G. Burmester

发表论文 262 篇 · 总被引 17267 次 · h-index 52

代表论文

• Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis (2023 · RMD Open · 被引 197)
• EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update. (2026 · Annals of the Rheumatic Diseases · 被引 55)
• Long-term safety and efficacy of sarilumab with or without background csDMARDs in rheumatoid arthritis (2023 · Rheumatology · 被引 14)
• Pharmacokinetics and safety of candidate tocilizumab biosimilar CT-P47 versus reference tocilizumab: a randomized, double-blind, single-dose phase I study (2023 · Expert Opinion on Investigational Drugs · 被引 12)
• OP0045 EULAR POINTS TO CONSIDER ON THE INITIATION OF TARGETED THERAPIES IN PATIENTS WITH INFLAMMATORY ARTHRITIDES AND A HISTORY OF CANCER (2023 · Annals of the Rheumatic Diseases · 被引 7)
• Improvement of humoral immunity by repeated dose-intensified COVID-19 vaccinations in primary non- to low-responders and B cell deficient rheumatic disease patients (2023 · Journal of Autoimmunity · 被引 5)